Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 1/20 | 0.51 |
| ▸ | NAMPT | P43490 | 2/20 | 0.50 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | GNAI3 | P08754 | 3/20 | 0.49 |
| ▸ | GNAO1 | P09471 | 3/20 | 0.49 |
| ▸ | GNAI1 | P63096 | 3/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.49 |
| ▸ | NAAA | Q02083 | 1/20 | 0.49 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | CNR1 | P21554 | 1/20 | 0.45 |
| ▸ | CNR2 | P34972 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | EPHX1 | P07099 | 4/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7091820 | 0.84 | HTT (0.54) | HTTNAMPTEPHX2TDP1NAAA | |
| SCHEMBL7090664 | 0.84 | HTT (0.54) | HTTNAMPTEPHX2TDP1NAAA | |
| SCHEMBL10739485 | 0.84 | TDP1 (0.65) | HTTNAMPTTDP1NAAAMEN1 | |
| SCHEMBL28165171 | 0.84 | TDP1 (0.65) | HTTNAMPTTDP1NAAAMEN1 | |
| SCHEMBL28273729 | 0.84 | TDP1 (0.65) | HTTNAMPTTDP1NAAAMEN1 | |
| SCHEMBL24176160 | 0.84 | TDP1 (0.65) | HTTNAMPTTDP1NAAAMEN1 | |
| SCHEMBL4285086 | 0.84 | TDP1 (0.65) | HTTNAMPTTDP1NAAAMEN1 | |
| SCHEMBL10739048 | 0.84 | TDP1 (0.65) | HTTNAMPTTDP1NAAAMEN1 | |
| SCHEMBL7094705 | 0.83 | HTT (0.53) | HTTNAMPTEPHX2TDP1NAAA | |
| SCHEMBL7092141 | 0.83 | HTT (0.53) | HTTNAMPTEPHX2TDP1NAAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102245688-B | Conductive composite material and thermoelectric device comprising same | 3M INNOVATIVE PROPERTIES CO | 2014-03-12 | — | — | CN | claimed |
| CN-102245688-A | Conductive composite material and thermoelectric device comprising same | 3M INNOVATIVE PROPERTIES CO | 2011-11-16 | — | — | CN | claimed |
| CN-116102913-B | Water-based static electricity conducting anti-corrosion UV (ultraviolet) curing coating and preparation method and application thereof | 安庆飞凯新材料有限公司 | 2024-06-18 | — | — | CN | disclosed |
| EP-3681504-B1 | METHODS OF DETECTION USING X-RAY FLUORESCENCE | ICAGEN INC (US) | 2023-08-23 | — | — | EP | disclosed |
| CN-116102913-A | Water-based static electricity conducting anti-corrosion UV (ultraviolet) curing coating and preparation method and application thereof | 安庆飞凯新材料有限公司 | 2023-05-12 | — | — | CN | disclosed |
| US-11573224-B2 | Methods of detection using X-ray fluorescence | ICAGEN, LLC (US) | 2023-02-07 | — | — | US | disclosed |
| US-20200278346-A1 | METHODS OF DETECTION USING X-RAY FLUORESCENCE | ADJACENT ACQUISITION CO., LLC | 2020-09-03 | — | — | US | disclosed |
| EP-3681504-A1 | METHODS OF DETECTION USING X-RAY FLUORESCENCE | Icagen, Inc. (US) | 2020-07-22 | — | — | EP | disclosed |
| WO-2019055754-A1 | METHODS OF DETECTION USING X-RAY FLUORESCENCE | ICAGEN, INC. (US) | 2019-03-21 | — | — | WO | disclosed |
| CN-102245688-B | Conductive composite material and thermoelectric device comprising same | 3M INNOVATIVE PROPERTIES CO | 2014-03-12 | — | — | CN | disclosed |
| CN-102442970-A | Thiazole compounds as cannabinoid receptor ligands and uses thereof | ABBOTT LAB | 2012-05-09 | — | — | CN | disclosed |
| CN-1242007-A | Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising such compounds, and methods of inhibiting beta amyloid peptide release and/or its synthesis using such compounds | ELAND PHARMACEUTICAL CORP (US) | 2000-01-19 | — | — | CN | disclosed |
| CN-1040876-C | New derivatives of erythromycin, their preparation process, their use as medicaments | ROUSSEL UCLAF (FR) | 1998-11-25 | — | — | CN | disclosed |
| CN-1036520-C | 1,4-diazepine derivative and its pharmaceutical use | EISAI CO LTD (JP) | 1997-11-26 | — | — | CN | disclosed |
| EP-0339599-B1 | Process for producing acylaromatic compounds | SUMITOMO CHEMICAL CO (JP) | 1996-08-21 | — | — | EP | disclosed |
| CN-1121076-A | 1,4-diazepine derivative and its pharmaceutical use | EISAI CO LTD (JP) | 1996-04-24 | — | — | CN | disclosed |
| CN-1028640-C | 1, 4-diazepine derivatives and their use as herbicides | EISAI CO LTD (JP) | 1995-05-31 | — | — | CN | disclosed |
| US-5235068-A | Using a boron trifluoride complex catalyst to react an aromatic compound and anhydride or acid | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1993-08-10 | — | — | US | disclosed |
| CN-1042356-A | 1, 4-diaza * derivatives and their pharmaceutical use | EISAI CO LTD (JP) | 1990-05-23 | — | — | CN | disclosed |
| EP-0339599-A2 | Process for producing acylaromatic compounds | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1989-11-02 | — | — | EP | disclosed |